Business news for the stock market
Dr. Hönle AG: Hoenle Group achieves EBITDA of EUR 3.6 million with EUR 69.8 million in sales after nine months
Gilching (pta008/07.08.2025/08:30 UTC+2)
- Hönle Group achieves revenue of €69.8 million (-3%) in a difficult market environment in the first nine months
- EBITDA is €3.6 million (-12%)
- Operating cash flow of €3.7 million generated
Geopolitical uncertainties continue to impact the investment climate. This impacted the Hönle Group's business performance in the first nine months of the 2024/25 financial year. The Adhesive Systems business unit was particularly affected, while the Curing business unit remained robust despite discontinuing unprofitable product lines that were not part of the core business. In contrast, the disinfection business unit using environmentally friendly UV technology performed well. Overall, sales declined from T€ 72,056 in the previous year to T€ 69,809 in the current financial year.
Savings in logistics, marketing, and consulting services contributed to a reduction in other operating expenses by T€ 921 to T€ 10,571. EBITDA amounted to T€ 3,554 (previous year: T€ 4,023). After depreciation and amortization, the operating result (EBIT) was T€ -554 (previous year: T€ -118), and after interest and taxes, the result for the period was T€ -1,320 (previous year: T€ -946).
Outlook
Curing Business Unit
In the Curing business unit, Hönle has defined curing systems for packaging printing, coatings on two- and three-dimensional objects, technical films, and labels as strategic focus areas. Increased print quality requirements and high demands on functional surface coatings, as well as the growing need for integrated process control, offer good growth opportunities for UV, UV-LED, and IR systems in many industrial application areas. In close coordination with key customers and their requirements, Hönle continuously implements innovations in processes for curing solutions and recently has won several attractive projects with industrial customers. One example of these innovations is the recently launched high-precision UV dose measurement system UV Scan MACS for optimized process control. Hönle also has entered into a cooperation with a manufacturer of paints and coating materials to jointly develop and market optimal solutions for a wide variety of applications. Through innovative process solutions for industrial curing applications and continuous profit optimization in the OEM and after-sales sectors, the Management Board expects increasing sales and earnings contributions in the coming years.
Adhesive Systems Business Unit
Hönle is continuously expanding its product range of adhesives for its strategic focus areas of electronics, medical, and optics, increasingly focusing on UV-curing adhesives and the optimized use of UV curing systems, which offer advantages in terms of heat input and processing speed. In close cooperation with customers, optimal solutions for the respective application areas are currently being developed in several promising projects. Despite the current reluctance of customers in the automotive sector, the Management Board expects significant sales growth in the coming years, particularly in Asia and North America. In addition to increasing sales, improvements in internal processes and regular streamlining of the product range are expected to contribute to a sustainable improvement in results.
Disinfection Business Unit
In the Disinfection business unit, Hönle offers the complete range of services for the disinfection process, including low-pressure lamps, medium-pressure lamps, LEDs, and pulsed UV light as well as microbiological services. In addition to established fields of application such as ballast water disinfection, new applications are continuously being developed. The qualification of components for the treatment of ultrapure water for customers in the semiconductor industry is progressing and, as planned, generating initial revenue this financial year. Expressions of interest for equipping additional semiconductor plants have already been received. Sales markets in the food industry are also developing positively, where, in addition to the wide range of different disinfection qualities, regular quality control using bioindicators is meeting strong demand. Disinfection with ultraviolet radiation is reliable, efficient, and environmentally friendly and, according to the Management Board, will continue to grow in the coming years both in existing markets and in new fields of application, particularly in Asia and North America.
Overall assessment of the future development of the business
As communicated in the announcement of August 5, 2025, the Management Board expects the Hönle Group to generate sales of between € 92 million and € 94 million in the 2024/25 financial year (PY: € 98.7 million). Due to the cost-cutting measures implemented, it expects operating earnings before interest, taxes, depreciation and amortization (EBITDA) of between € 5 million and € 6 million (PY adjusted EBITDA: € 5.5 million) despite the lower sales level.
Further Information
Q3 Statement 2024/25: https://www.hoenle.com/investor-relation/report
About Hönle
The Dr. Hönle AG is a listed technology company based in Gilching. The Hönle Group develops innovative solutions with a focus on UV technology for a wide range of industrial applications with its 600 employees. A business unit includes the development and sale of industrial adhesives and adhesive curing devices. The company also produces drying systems for the printing and coating industry. Another business area deals with the environmentally friendly disinfection of water, air and surfaces. The Hönle Group supplies technology and global market leaders worldwide and is represented in over 20 countries with its own companies and partner companies.
(end)
Emitter: |
Dr. Hönle AG Nicolaus-Otto-Str. 2 82205 Gilching Germany |
![]() |
---|---|---|
Contact Person: | Peter Weinert | |
Phone: | +49 8105 2083 173 | |
E-Mail: | peter.weinert@hoenle.de | |
Website: | www.hoenle.de | |
ISIN(s): | DE0005157101 (Share) | |
Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate |